Citations for
1HSPA9, SLC25A6
Mortalin (HSPA9) facilitates BRAF-mutant tumor cell survival by suppressing ANT3-mediated mitochondrial membrane permeability.
Wu PK, Hong SK, Chen W, Becker AE, Gundry RL, Lin CW, Shao H, Gestwicki JE, Park JI.
Sci Signal 13(622). pii: eaay1478. doi: 10.1126/scisignal.aay1478. 2020
2HSPA9, PARK7
Mortalin and DJ-1 coordinately regulate hematopoietic stem cell function through the control of oxidative stress.
Tai-Nagara I, Matsuoka S, Ariga H, Suda T.
Blood 123(1):41-50. doi: 10.1182/blood-2013-06-508333. Epub 2013 Nov 15. 2014
3HSPA8, HSPA9
Analysis of HSPA8 and HSPA9 mRNA expression and promoter methylation in the brain and blood of Alzheimer's disease patients.
Silva PN, Furuya TK, Braga IL, Rasmussen LT, Labio RW, Bertolucci PH, Chen ES, Turecki G, Mechawar N, Payão SL, Mill J, Smith MC.
J Alzheimers Dis 38(1):165-70. doi: 10.3233/JAD-130428. 2014
4ACSL5, HSPA9
TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.
Klaus C, Kaemmerer E, Reinartz A, Schneider U, Plum P, Jeon MK, Hose J, Hartmann F, Schnölzer M, Wagner N, Kopitz J, Gassler N.
Cell Tissue Res 357(1):267-78. doi: 10.1007/s00441-014-1826-8. Epub 2014 Apr 29. 2014
5HSCB, HSPA9, ISCU, LYRM4, NFS1
Human mitochondrial chaperone (mtHSP70) and cysteine desulfurase (NFS1) bind preferentially to the disordered conformation, whereas co-chaperone (HSC20) binds to the structured conformation of the iron-sulfur cluster scaffold protein (ISCU).
Cai K, Frederick RO, Kim JH, Reinen NM, Tonelli M, Markley JL.
J Biol Chem 288(40):28755-70. doi: 10.1074/jbc.M113.482042. Epub 2013 Aug 12. 2013
6CDKN1A, HSPA9
A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase.
Wu PK, Hong SK, Veeranki S, Karkhanis M, Starenki D, Plaza JA, Park JI.
Mol Cell Biol 33(20):4051-67. doi: 10.1128/MCB.00021-13. Epub 2013 Aug 19. 2013
7BCL2, BCL2L1, HSPA9
Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization.
Saxena N, Katiyar SP, Liu Y, Grover A, Gao R, Sundar D, Kaul SC, Wadhwa R.
Biosci Rep 33(5). pii: e00073. doi: 10.1042/BSR20130034. 2013
8FXN, HSCB, HSPA9, ISCU
HSC20 interacts with frataxin and is involved in iron-sulfur cluster biogenesis and iron homeostasis.
Shan Y, Cortopassi G.
Hum Mol Genet 21(7):1457-69. doi: 10.1093/hmg/ddr582. Epub 2011 Dec 13. 2012
9DNLZ, HSPA9
A conserved histidine in human DNLZ/HEP is required for stimulation of HSPA9 ATPase activity.
Zhai P, Vu MT, Hoff KG, Silberg JJ.
Biochem Biophys Res Commun 408(4):589-94. Epub 2011 Apr 21. 2011
10HSPA9
Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.
Lu WJ, Lee NP, Kaul SC, Lan F, Poon RT, Wadhwa R, Luk JM.
Cell Death Differ 18(6):1046-56. Epub 2011 Jan 14. 2011
11HSPA9, PRKN
Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
Yang H, Zhou X, Liu X, Yang L, Chen Q, Zhao D, Zuo J, Liu W.
Biochem Biophys Res Commun 410(1):114-20. Epub 2011 May 26. 2011
12HSPA9, RXRA
Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma.
Shih YY, Lee H, Nakagawara A, Juan HF, Jeng YM, Tsay YG, Lin DT, Hsieh FJ, Pan CY, Hsu WM, Liao YF.
PLoS One 6(10):e26236. doi: 10.1371/journal.pone.0026236. Epub 2011 Oct 14. 2011
13HSPA9, PINK1, PRKN
Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
Rakovic A, Grünewald A, Seibler P, Ramirez A, Kock N, Orolicki S, Lohmann K, Klein C.
Hum Mol Genet 19(16):3124-37. Epub 2010 May 27.PMID: 20508036 2010
14HSPA9
Magnetic nanoparticle-based isolation of endocytic vesicles reveals a role of the heat shock protein GRP75 in macromolecular delivery.
Wittrup A, Zhang SH, Svensson KJ, Kucharzewska P, Johansson MC, Mörgelin M, Belting M.
Proc Natl Acad Sci U S A 107(30):13342-7. Epub 2010 Jul 12. 2010
15HSPA9
Knockdown of mortalin within the medial prefrontal cortex impairs normal sensorimotor gating.
Gabriele N, Pontoriero GF, Thomas N, Shethwala SK, Pristupa ZB, Gabriele JP.
Synapse 64(11):808-13. 2010
16HSPA9
Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.
Burbulla LF, Schelling C, Kato H, Rapaport D, Woitalla D, Schiesling C, Schulte C, Sharma M, Illig T, Bauer P, Jung S, Nordheim A, Schöls L, Riess O, Krüger R.
Hum Mol Genet 19(22):4437-52. Epub 2010 Sep 2. 2010
17HSPA9
Reconstitution of the mitochondrial Hsp70 (mortalin)-p53 interaction using purified proteins--identification of additional interacting regions.
Iosefson O, Azem A.
FEBS Lett 584(6):1080-4. Epub 2010 Feb 12. 2010
18HSPA9
Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
Pilzer D, Saar M, Koya K, Fishelson Z.
Int J Cancer 126(6):1428-35. 2010
19HSPA9
Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease.
De Mena L, Coto E, Sánchez-Ferrero E, Ribacoba R, Guisasola LM, Salvador C, Blázquez M, Alvarez V.
J Neural Transm 116(10):1289-93. Epub 2009 Aug 6. 2009
20HSPA9
Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders.
Gabriele J, Pontoriero GF, Thomas N, Thomson CA, Skoblenick K, Pristupa ZB, Mishra RK.
Cell Stress Chaperones 14(6):555-67. Epub 2009 Mar 12. 2009
21HSPA9
From proliferative to neurological role of an hsp70 stress chaperone, mortalin.
Deocaris CC, Kaul SC, Wadhwa R.
Biogerontology 9(6):391-403. Epub 2008 Sep 4. Review. 2008
22HSPA9
Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM, Lee H, Juan HF, Shih YY, Wang BJ, Pan CY, Jeng YM, Chang HH, Lu MY, Lin KH, Lai HS, Chen WJ, Tsay YG, Liao YF, Hsieh FJ.
Clin Cancer Res 14(19):6237-45. 2008
23FXN, LYRM4, FRDA, HSPA9
Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones.
Shan Y, Napoli E, Cortopassi G.
Hum Mol Genet 16(8):929-41. Epub 2007 Mar 1. 2007
24HSPA9
Involvement of mortalin in cellular senescence from the perspective of its mitochondrial import, chaperone, and oxidative stress management functions.
Yaguchi T, Aida S, Kaul SC, Wadhwa R.
Ann N Y Acad Sci 1100:306-11. Review. 2007
25HSPA9
Mortalin controls centrosome duplication via modulating centrosomal localization of p53.
Ma Z, Izumi H, Kanai M, Kabuyama Y, Ahn NG, Fukasawa K.
Oncogene 25(39):5377-90. Epub 2006 Apr 17. 2006
26HSPA9
Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis.
Wadhwa R, Takano S, Kaur K, Deocaris CC, Pereira-Smith OM, Reddel RR, Kaul SC.
Int J Cancer. 118(12):2973-80. 2006
27HSPA9,HSPD1
Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60.
Wadhwa R, Takano S, Kaur K, Aida S, Yaguchi T, Kaul Z, Hirano T, Taira K, Kaul SC.
Biochem J 391(Pt 2):185-90. 2005
28HSPA9, HSP90B1
Identification and characterization of molecular interactions between glucose-regulated proteins (GRPs) mortalin/GRP75/peptide-binding protein 74 (PBP74) and GRP94.
Takano S, Wadhwa R, Mitsui Y, Kaul SC.
Biochem J 357(Pt 2):393-8. 2001
29HSPA9
Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75.
Ran Q, Wadhwa R, Kawai R, Kaul SC, Sifers RN, Bick RJ, Smith JR, Pereira-Smith OM.
Biochem Biophys Res Commun 275(1):174-9. 2000
30HSPA9
Mouse and human chromosomal assignments of mortalin, a novel member of the murine hsp70 family of proteins.
Kaul SC, et al.
FEBS Lett 361 : 269-272. 1995
31HSPA9
Cloning and subcellular localization of human mitochondrial hsp70.
Bhattacharyya T, Karnezis AN, Murphy SP, Hoang T, Freeman BC, Phillips B, Morimoto RI.
J Biol Chem 270(4):1705-10. 1995
32HSPA9
Cloning of the gene encoding peptide-binding protein 74 shows that it is a new member of the heat shock protein 70 family.
Domanico SZ, DeNagel DC, Dahlseid JN, Green JM, Pierce SK.
Mol Cell Biol 13(6):3598-610. 1993